Who
Vickie L. Capps
Director
Company insider
Files Form 4 as: Director, Janux Therapeutics; Director, Orthofix Medical; Director, Amedisys; Director, Nuvasive; Director, Otonomy; Director, ARS Pharmaceuticals; Director, Synthorx; Director, Connecture.
In numbers
- Trades disclosed
- 289
- Buys
- 10
- Sells
- 18
- Bought
- $861K
- Sold
- $5.4M
- Companies
- 10
- Companies where not an officer
- 9
- First trade
- 4 Jan 2006
- Last trade
- 11 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 12 Jun 2026 | JANX Janux TherapeuticsBiotechnology | SEC FORM 4 Code A | —5,500 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | JANX Janux Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,500 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | JANX Janux Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,500 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | JANX Janux TherapeuticsBiotechnology | SEC FORM 4 Code A | —5,500 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | —14,965 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | —14,965 at $0.00 | filing |
| 10 Mar 2026filed 10 Mar 2026 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Bought | $1,244100 at $12.44 | filing |
| 10 Mar 2026filed 10 Mar 2026 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Bought | $30K2,400 at $12.45 | filing |
| 10 Mar 2026filed 10 Mar 2026 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Bought | $1,244100 at $12.44 | filing |
| 10 Mar 2026filed 10 Mar 2026 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Bought | $30K2,400 at $12.45 | filing |
| 9 Mar 2026filed 10 Mar 2026 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Bought | $31K2,500 at $12.48 | filing |
| 9 Mar 2026filed 10 Mar 2026 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Bought | $31K2,500 at $12.48 | filing |
| 14 Aug 2025filed 14 Aug 2025 | Amedisys | SEC FORM 4 Code D | —9,818 | filing |
| 18 Jun 2025filed 23 Jun 2025 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | —18,841 at $0.00 | filing |
| 11 Jun 2025filed 13 Jun 2025 | JANX Janux Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,667 at $0.00 | filing |
| 11 Jun 2025filed 13 Jun 2025 | JANX Janux TherapeuticsBiotechnology | SEC FORM 4 Code A | —3,750 at $0.00 | filing |
| 3 May 2025filed 6 May 2025 | Amedisys | SEC FORM 4 Code A | —1,690 at $0.00 | filing |
| 11 Mar 2025filed 13 Mar 2025 | OFIX Orthofix Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —35,270 at $0.00 | filing |
| 11 Mar 2025filed 13 Mar 2025 | OFIX Orthofix MedicalMedical Devices | SEC FORM 4 Code A | —3,093 at $0.00 | filing |
| 5 Nov 2024filed 7 Nov 2024 | JANX Janux TherapeuticsBiotechnology | SEC FORM 4 Code J | —2,305 at $0.00 | filing |
News
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Orthofix Medical Inc. (NASDAQ: OFIX)OFIX · prnewswire.com · 9 Oct 2026
0 headlines in the last 90 days name Vickie L. Capps; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.